Abnormal islet sphingolipid metabolism in type 1 diabetes

被引：0
|
作者：
Laurits J. Holm
Lars Krogvold
Jane P. Hasselby
Simranjeet Kaur
Laura A. Claessens
Mark A. Russell
Clayton E. Mathews
Kristian F. Hanssen
Noel G. Morgan
Bobby P. C. Koeleman
Bart O. Roep
Ivan C. Gerling
Flemming Pociot
Knut Dahl-Jørgensen
Karsten Buschard
机构：
[1] Rigshospitalet,The Bartholin Institute, Department of Pathology
[2] Copenhagen Biocenter,Division of Paediatric and Adolescent Medicine
[3] Oslo University Hospital,Faculty of Odontology
[4] University of Oslo,Department of Pathology
[5] Rigshospitalet,Department of Immunohaematology & Blood Transfusion
[6] Steno Diabetes Center Copenhagen,Department of Medical Genetics
[7] Leiden University Medical Center,Institute of Biomedical and Clinical Sciences
[8] University Medical Center,Department of Pathology
[9] University of Exeter Medical School,Department of Endocrinology
[10] University of Florida,Department of Diabetes Immunology, Diabetes & Metabolism Research Institute
[11] Oslo University Hospital,Department of Medicine
[12] Beckman Research Institute at the City of Hope,Faculty of Medicine
[13] University of Tennessee,undefined
[14] University of Oslo,undefined
来源：
Diabetologia | 2018年 / 61卷
关键词：
Fenofibrate; Gene polymorphisms; GWAS; Islet autoimmunity; NOD mice; Prevention; Sphingolipid; Sulfatide; T cells; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1650 / 1661
页数：11
相关论文
共 50 条
  • [1] Abnormal islet sphingolipid metabolism in type 1 diabetes
    Holm, Laurits J.
    Krogvold, Lars
    Hasselby, Jane P.
    Kaur, Simranjeet
    Claessens, Laura A.
    Russell, Mark A.
    Mathews, Clayton E.
    Hanssen, Kristian F.
    Morgan, Noel G.
    Koeleman, Bobby P. C.
    Roep, Bart O.
    Gerling, Ivan C.
    Pociot, Flemming
    Dahl-Jorgensen, Knut
    Buschard, Karsten
    DIABETOLOGIA, 2018, 61 (07) : 1650 - 1661
  • [2] IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants
    Denroche, Heather C.
    Verchere, C. Bruce
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2018, 60 (02) : R57 - R75
  • [3] Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes
    Bellini, Lara
    Campana, Melanie
    Mahfouz, Rana
    Carlier, Aurelie
    Veret, Julien
    Magnan, Christophe
    Hajduch, Eric
    Le Stunff, Herve
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (08) : 1037 - 1050
  • [4] Sphingolipid metabolism in type 2 diabetes and associated cardiovascular complications
    Sui, Jing
    He, Mingqian
    Wang, Yue
    Zhao, Xinrui
    He, Yizhi
    Shi, Bingyin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 3603 - 3614
  • [5] Altered lipid metabolism preceding onset of islet autoimmunity and type 1 diabetes
    Marinkovic, T.
    Hyotylainen, T.
    Mattila, I.
    Poho, P.
    Knip, M.
    Oresic, M.
    DIABETOLOGIA, 2015, 58 : S150 - S150
  • [6] Induced mouse models of abnormal sphingolipid metabolism
    Suzuki, K
    Vanier, MT
    Suzuki, K
    JOURNAL OF BIOCHEMISTRY, 1998, 124 (01): : 8 - 19
  • [7] Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
    Blachnio-Zabielska, Agnieszka
    Hajduch, Eric
    Le Stunff, Herve
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [8] TYPE 1 DIABETES Islet renovation
    Crunkhorn, Sarah
    NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) : 976 - 976
  • [9] Islet transplantation in type 1 diabetes
    de Kort, Hanneke
    de Koning, Eelco J.
    Rabelink, Ton J.
    Bruijn, Jan A.
    Bajema, Ingeborg M.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342 : 426 - 432
  • [10] Circulating sphingolipid biomarkers in models of type 1 diabetes
    Fox, Todd E.
    Bewley, Maria C.
    Unrath, Kellee A.
    Pedersen, Michelle M.
    Anderson, Robert E.
    Jung, Dae Young
    Jefferson, Leonard S.
    Kim, Jason K.
    Bronson, Sarah K.
    Flanagan, John M.
    Kester, Mark
    JOURNAL OF LIPID RESEARCH, 2011, 52 (03) : 509 - 517
12345